Published on: June 22, 2024
HUMAN AFRICAN TRYPANOSOMIASIS (HAT)
HUMAN AFRICAN TRYPANOSOMIASIS (HAT)
NEWS – Chad has become the first country in 2024 and the 51st globally to eliminate a neglected tropical disease (NTD) — the gambiense form of human African trypanosomiasis (HAT)
HUMAN AFRICAN TRYPANOSOMIASIS (HAT)
Overview
- Also known as sleeping sickness.
- Caused by protozoan parasites transmitted by infected tsetse flies.
- Endemic in sub-Saharan Africa.
Forms of HAT
- Trypanosoma brucei gambiense
- Found in 24 countries of West and Central Africa.
- Accounts for 92% of reported cases.
- Causes chronic illness.
- Infection can last months or years without major signs or symptoms.
- Symptoms appear when the disease is advanced, often affecting the central nervous system.
- Trypanosoma brucei rhodesiense
- Found in 13 countries of Eastern and Southern Africa.
- Accounts for 8% of reported cases.
- Causes acute disease.
- Symptoms appear a few weeks or months after infection.
- Disease develops rapidly, with multi-organ invasion including the brain.
Transmission
- Transmitted by certain species of tsetse flies inhabiting sub-Saharan Africa.
- Rural populations dependent on agriculture, fishing, animal husbandry, or hunting are most exposed.
Elimination Progress
- WHO has validated the elimination of the gambiense form of HAT in seven countries:
- Togo (2020)
- Benin (2021)
- Ivory Coast (2021)
- Uganda (2022)
- Equatorial Guinea (2022)
- Ghana (2023)
- Chad (2024)